BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 32929153)

  • 1. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis.
    Sun Q; Ye Z; Qin Y; Fan G; Ji S; Zhuo Q; Xu W; Liu W; Hu Q; Liu M; Zhang Z; Xu X; Yu X
    Oncogene; 2020 Oct; 39(42):6572-6588. PubMed ID: 32929153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. dCK negatively regulates the NRF2/ARE axis and ROS production in pancreatic cancer.
    Hu Q; Qin Y; Xiang J; Liu W; Xu W; Sun Q; Ji S; Liu J; Zhang Z; Ni Q; Xu J; Yu X; Zhang B
    Cell Prolif; 2018 Aug; 51(4):e12456. PubMed ID: 29701272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of Nrf2 by Sulforaphane Inhibits High Glucose-Induced Progression of Pancreatic Cancer via AMPK Dependent Signaling.
    Chen X; Jiang Z; Zhou C; Chen K; Li X; Wang Z; Wu Z; Ma J; Ma Q; Duan W
    Cell Physiol Biochem; 2018; 50(3):1201-1215. PubMed ID: 30355942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated metabolic reprogramming and ROS detoxification.
    Wu YS; Looi CY; Subramaniam KS; Masamune A; Chung I
    Oncotarget; 2016 Jun; 7(24):36719-36732. PubMed ID: 27167341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paracrine IL-6 signaling mediates the effects of pancreatic stellate cells on epithelial-mesenchymal transition via Stat3/Nrf2 pathway in pancreatic cancer cells.
    Wu YS; Chung I; Wong WF; Masamune A; Sim MS; Looi CY
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):296-306. PubMed ID: 27750041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of long non‑coding RNA DLEU2 suppresses idiopathic pulmonary fibrosis by regulating the microRNA‑369‑3p/TRIM2 axis.
    Yi H; Luo D; Xiao Y; Jiang D
    Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PIN1 Maintains Redox Balance via the c-Myc/NRF2 Axis to Counteract Kras-Induced Mitochondrial Respiratory Injury in Pancreatic Cancer Cells.
    Liang C; Shi S; Liu M; Qin Y; Meng Q; Hua J; Ji S; Zhang Y; Yang J; Xu J; Ni Q; Li M; Yu X
    Cancer Res; 2019 Jan; 79(1):133-145. PubMed ID: 30355620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TRIM2 regulates the development and metastasis of tumorous cells of osteosarcoma.
    Qin Y; Ye J; Zhao F; Hu S; Wang S
    Int J Oncol; 2018 Oct; 53(4):1643-1656. PubMed ID: 30066883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway.
    Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X
    J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TRIM16 protects from OGD/R-induced oxidative stress in cultured hippocampal neurons by enhancing Nrf2/ARE antioxidant signaling via downregulation of Keap1.
    Ren X; Yu J; Guo L; Ma H
    Exp Cell Res; 2020 Jun; 391(1):111988. PubMed ID: 32251645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and the potential functions of TRIM32 in lung cancer tumorigenesis.
    Yin H; Li Z; Chen J; Hu X
    J Cell Biochem; 2019 Apr; 120(4):5232-5243. PubMed ID: 30378152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MYEOV increases HES1 expression and promotes pancreatic cancer progression by enhancing SOX9 transactivity.
    Liang E; Lu Y; Shi Y; Zhou Q; Zhi F
    Oncogene; 2020 Oct; 39(41):6437-6450. PubMed ID: 32879444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced epinephrine promotes epithelial-to-mesenchymal transition and stemness of CRC through the CEBPB/TRIM2/P53 axis.
    Zhou Z; Shu Y; Bao H; Han S; Liu Z; Zhao N; Yuan W; Jian C; Shu X
    J Transl Med; 2022 Jun; 20(1):262. PubMed ID: 35672760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanical Regulation of Redox Balance via the Induction of the PIN1/NRF2/ARE Axis in Pancreatic Cancer.
    Liang C; Rong Z; Tuerhong A; Meng Q; Hua J; Liu J; Zhang B; Wang W; Yu X; Shi S; Xu J
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
    Kanno T; Tanaka K; Yanagisawa Y; Yasutake K; Hadano S; Yoshii F; Hirayama N; Ikeda JE
    Free Radic Biol Med; 2012 Dec; 53(11):2028-42. PubMed ID: 23000247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chalcone flavokawain A attenuates TGF-β1-induced fibrotic pathology via inhibition of ROS/Smad3 signaling pathways and induction of Nrf2/ARE-mediated antioxidant genes in vascular smooth muscle cells.
    Hseu YC; Yang TY; Li ML; Rajendran P; Mathew DC; Tsai CH; Lin RW; Lee CC; Yang HL
    J Cell Mol Med; 2019 Feb; 23(2):775-788. PubMed ID: 30549180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Role of TRIM2 in Human Diseases.
    Xiao M; Li J; Liu Q; He X; Yang Z; Wang D
    Biomed Res Int; 2022; 2022():9430509. PubMed ID: 36051486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANLN-induced EZH2 upregulation promotes pancreatic cancer progression by mediating miR-218-5p/LASP1 signaling axis.
    Wang A; Dai H; Gong Y; Zhang C; Shu J; Luo Y; Jiang Y; Liu W; Bie P
    J Exp Clin Cancer Res; 2019 Aug; 38(1):347. PubMed ID: 31395079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
    Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
    Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anti-oxidative transcription factor Nuclear factor E2 related factor-2 (Nrf2) counteracts TGF-β1 mediated growth inhibition of pancreatic ductal epithelial cells -Nrf2 as determinant of pro-tumorigenic functions of TGF-β1.
    Genrich G; Kruppa M; Lenk L; Helm O; Broich A; Freitag-Wolf S; Röcken C; Sipos B; Schäfer H; Sebens S
    BMC Cancer; 2016 Feb; 16():155. PubMed ID: 26915435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.